In pathophysiological conditions such as thyroid disorder, vasoactive intestinal polypeptide stimulates PRL synthesis and thyrotropin-releasing hormone increases secretion; in renal impairment, it decreases PRL clearance and increases serum PRL levels. Here, VIP is linked to thyroid gland disorder.